This recently in from:
Yesterday the U.S. Food and Drug Administration approved the drug Northera — the brand name for droxidopa — to treat orthostatic hypotension in Parkinson’s patients.
Learn more about the FDA’s decision.
This approval after a lengthy review process is a true victory for people with Parkinson’s experiencing this common and debilitating symptom. Orthostatic hypotension is a sudden drop in blood pressure when standing, which can cause dizziness, falls and injury.
Since taking Northera can raise blood pressure when lying down, users are cautioned to sleep with their head and upper body elevated.